To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Lung cancer
Cell culture and mouse studies suggest the GLS inhibitor CB-839 could help treat KRAS-mutant lung cancers that
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury